Coronavirus India Highlights: Indian pharmaceutical major Zydus Cadila is likely to apply to the central drugs regulator asking for emergency use authorisation for its Covid vaccine ZyCoV-D next week, PTI quoted official sources as saying on Friday. If approved, it will be the world’s first DNA vaccine against the virus and the fourth to be available in the country. “The analysis of the phase-three trial data is almost ready and the company has informed the government that it could apply for emergency use licensure for its COVID-19 vaccine next week,” PTI quoted an official source as saying.
The World health Organisation (WHO) has accepted Bharat Biotech’s Expression of Interest (EoI) for Covid-19 vaccine Covaxin and scheduled a pre-submission meeting on June 23. Though the meeting will not be a detailed review on the vaccine, the manufacturer will have an opportunity to put forth a summary on overall quality of the jab. The information was uploaded in the WHO website in the Status of Covid-19 Vaccines within WHO EUL-PQ evaluation process document.
The Centre, on Friday, informed that more than 2.58 crore doses of Covid-19 vaccines are still available with states with over 19 lakh more being dispatched in the coming 3 days.
Meanwhile, the Delhi High Court warned that a breach of Covid protocol will only hasten the third wave. It said so while taking note of the violations in markers in the capital following the easing of restrictions this week. The court asked authorities to take strict measures against violators and sensitise shopkeepers. It also directed the Centre and Delhi government to submit status reports about the same.
Prime Minister Narendra Modi, while launching six crash courses for frontline workers, said the government is planning to train over 1 lakh healthcare personnel.